8:55am ET
Health and Healthcare
Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst
The data is grim: cancer is increasing. Sales of these top oncology drugs are likely to increase as well.
Companies
/Healthcare
Bristol-Myers Squibb Company
$63.06
▲ $0.22 (+0.35%) today
Markets closed · 6:44am ET
BMY Coverage
Page 30
8:30am ET
Health and Healthcare
3 Likely Biotech Buyout Candidates
A new research report from the analysts at Cowen sees a potential wave of biotech deals, some of which could be of the blockbuster variety.
10:45am ET
Health and Healthcare
Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014
A new report from the pharmaceutical team at Credit Suisse highlights four top stocks to buy for the remainder of 2014
2:44pm ET
Health and Healthcare
ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms
ThinkstockBristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) had approved the drug ELIQUIS, as a treatment for Deep Vein Thrombosis and Pulmonary Embolisms. Each…
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Tuesday, July 2, 2014. They include Alcatel-Lucent, Apple, FireEye, JDSU Uniphase and solar stocks.
10:15am ET
Health and Healthcare
Upcoming Binary Events Could Lift These Health Care Stocks Much Higher
In a new report, the analysts at health care boutique Leerink highlight numerous upcoming catalysts for some top stocks in the sector. Catalysts may move the stocks sharply either way, depending on…
8:30am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Lululemon, Microsoft, NBG, Twitter, Whole Foods and More
These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 5, 2014. They include Apple, Lululemon, Microsoft, NBG, Twitter and Whole Foods.
8:20am ET
Health and Healthcare
Why You Buy Big Pharma If the Market Crashes
A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is large cap pharmaceuticals. Here are their top large cap pharmaceuticals to buy…
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Cisco, Kinder Morgan, Rackspace, Twitter and More
These are the top Wall Street analyst upgrades, downgrades and initiations seen on Thursday, May 15, 2014. They include Cisco Systems, Kinder Morgan, Rackspace, Twitter and L-3 Communications.
9:05am ET
Health and Healthcare
J.P. Morgan’s Top Biotech and Health Care Picks With Huge Upside
In a new research report, the J.P. Morgan health care team highlights their top names to buy after the sell-off that may provide investors some incredible outsized gains over the rest of…
8:45am ET
Health and Healthcare
J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now
Wikimedia CommonsWith the U.S. pharmaceutical group, and particularly the specialty pharmaceutical names, under pressure over recent trading sessions, the large biotechnology stocks were not the lone rangers when it came to the…
9:05am ET
Health and Healthcare
Four Upcoming Catalysts That Could Move Pharmaceutical Stocks
In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the Cowen 2014 Healthcare Conference by large cap pharmaceutical companies concerning upcoming events…
11:15am ET
Health and Healthcare
Mallinckrodt May Have to Pay More for Cadence
Cadence Pharmaceuticals agreed Tuesday to be bought out by Mallinckrodt for $1.3 billion, or a more than 27% premium to Monday's closing share price. Some investors may anticipate a sweetened offer.
cgblaine22 8:50am ET
Investing
The Best of the Best Picks of the Credit Suisse Top 50 Stocks
Frank Golhen, via Wikimedia CommonsMost of the firms that we cover on Wall Street have presented their high conviction stock picks for 2014. The analysts at Credit Suisse have taken a little…
7:30am ET
Health and Healthcare
Shire, Novartis Deals: Pharmaceutical Shakeups Continue
ThinkstockThe wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical company ViroPharma (NASDAQ: VPHM) in…